Last reviewed · How we verify
NCT02839525
The Effect of Nutritional Interventions on Exercise-induced Muscle Damage
NA trial testing Omega 3 in Muscle Damage in 2 participants. Completed in 9 February 2017.
9 January 2017
Quick facts
| Lead sponsor | Federal University of Health Science of Porto Alegre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 2 |
| Start date | 26 July 2016 |
| Primary completion | 9 January 2017 |
| Estimated completion | 9 February 2017 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Omega 3 — full drug profile →
- Isolate whey protein
- Omega 3 and Isolate whey protein
- Eccentric exercise
Conditions studied
- Muscle Damage — all drugs for Muscle Damage →
Sponsor
Federal University of Health Science of Porto Alegre
Who can join
Adults 18 to 40, female only, with Muscle Damage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a randomized, double-blinded, placebo-controlled trial that will include the participation of 69 women, aged 18-40 years. The aim of the study is to test nutritional strategies that help to minimize the effects of muscle damage induced by exercise. The procedures will be performed at the Federal University of Health of Porto Alegre (UFCSPA).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of omega-3 supplementation on muscle damage after resistance exercise in young women: a randomized placebo-controlled trial.
Loss LC, Benini D, de Lima-E-Silva FX, Möller GB, et al · · 2022 · cited 6× · PMID 34130550 · DOI 10.1177/02601060211022266
Verify or expand the search:
- PubMed search for NCT02839525
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Omega 3
Trials testing the same drug.
- NCT05774665 — Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression · Phase 2 · active not recruiting
- NCT06555705 — Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children · NA · completed
- NCT07138131 — Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia · NA · completed
- NCT06463535 — Effects of Omega-3 as an Adjunct to Non-Surgical Periodontal Therapy on Chemerin Level in Periodontitis Patients With Di · NA · completed
- NCT04411615 — Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery · NA · unknown
Other recruiting trials for Muscle Damage
Currently open trials in the same condition.
- NCT06837298 — The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery · NA · recruiting
- NCT06432868 — Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise · NA · recruiting
- NCT06992271 — Comparing Two Eccentric Protocols on Muscle Damage · NA · recruiting
- NCT04900506 — Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach · NA · active not recruiting
- NCT04549610 — HMB and Exercise-induced Muscle Damage · Phase 2, PHASE3 · recruiting
Other Federal University of Health Science of Porto Alegre trials
Trials by the same sponsor.
- NCT07432113 — Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syn · NA · not yet recruiting
- NCT07232862 — Analysis Of The Effect Of A Fine Manual Skills Intervention In A Specific Context On The Linguistic Processing of Health · NA · recruiting
- NCT07172698 — Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinso · NA · completed
- NCT06761963 — Chronic Effect of Whole-body Electrical Stimulation in COPD Patients · NA · not yet recruiting
- NCT05814432 — Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02839525 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of Health Science of Porto Alegre
- Last refreshed: 9 March 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02839525.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing